Skip to main content
. Author manuscript; available in PMC: 2020 Sep 4.
Published in final edited form as: Nanoscale. 2018 Mar 29;10(13):6113–6124. doi: 10.1039/C7NR09269E

Fig. 10.

Fig. 10

Biodistribution of the 64Cu-DOTA-FA-FI-G5·NHAc dendrimers in KB or A549 tumor-bearing athymic nude mice at 20 h pi (n = 6 per group, mean ± SD). Administration of the 64Cu-DOTA-FA-FI-G5·NHAc dendrimers (7.4 MBq) was through iv injection. The blocking study was performed by iv injection of 7.4 MBq of the 64Cu-DOTA-FA-FI-G5·NHAc dendrimers with co-injection of FA (100 μg per mouse) as a blocking agent.